Michael Aldridge

Senior executive with extensive background in the global biotechnology and pharmaceutical industries. Held leadership, strategic and financing roles in North American, European and Australian companies. Deep understanding of and strong relationships in all major international investment banking financing and merger and acquisition markets. Accomplished and results oriented team leader capable of starting, developing and building high-performing organizations. Developed Picato the FDA approved prescription topical gel to treat actinic keratosis.